Peer Review History

Original SubmissionOctober 21, 2019
Decision Letter - Kenji Hashimoto, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-19-29424

Dysfunctional neuroplasticity in newly arrived Middle Eastern refugees in the U.S.: Association with environmental exposures and mental health disorders

PLOS ONE

Dear Dr. Arnetz,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers addressed some minor comments about your manuscript. Please revise your manuscript carefully.

We would appreciate receiving your revised manuscript by Mar 23 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kenji Hashimoto, PhD

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript focussed an important issue, and it was well written. It will contribute much for mental health fields. The methodological and statistical is appropriate. The interpretation of the results is rational. I think it should be accepted in the present form.

Reviewer #2: This is an interesting paper where the authors have studied 64 newly arrived refugees from Syria and Iran living in Michigan USA. They were studied one month after their arrival by making an assessment on PTSD, depression, anxiety, self-reported mental health. neurotrophins- BDNF and NGF as proxy measures of neuroplasticity and exposure to heavy metals. The authors found independent associations between environmental exposures and neuroplasticity with different mental health problems. Few of the findings can be interpreted as different from what one expects.

As the authors argue this is a pioneer study where they have included two important measures, namely exposure to environmental toxins and neurobiological markers for measuring neuroplasticity in addition to classical descriptive studies in refugee trauma. This has certainly given an extra strength to this paper which will ultimately help us to understand refugee trauma mechanism better.

Abstract is well written and well presented. However, I wonder if the authors could avoid using the terminologies like predictor or predicted ( e.g. line 49 ) as this is not a longitudinal study and the direction of causality is thus not very obvious. I would suggest the authors to be a little bit careful when they speculate for their findings. In line 64-66, they argue for role of neutrophins as facilitator of apoptosis which is far away from existing knowledge and understanding of its roles.

Introduction. Well written with relevant literatures

Methods: Sample selection is somewhat limited and the sample size is also rather small. Choice of the instruments and statistical methods are quite well explained and good.

Results are presented well both in tables and texts. I am just curious to know if the authors have sometimes thought about using neuroplasticity as a dependent variable in their analyses. It could have been interesting to look that too.

Discussions are also well balanced and presented. However, I think that authors are quite optimistic for using sophisticated biological parameters is studying refugee trauma which is not always possible specially in low-and middle- income countries.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Suraj Bahadur Thapa

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response:

Thank you for alerting us to this requirement. We have now reviewed the template on the journal website and the manuscript has been formatted to meet the journals’ style requirements.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Response:

We will be uploading the de-identified dataset as supporting information files.

Reviewer #1: The manuscript focused an important issue, and it was well written. It will contribute much for mental health fields. The methodological and statistical is appropriate. The interpretation of the results is rational. I think it should be accepted in the present form.

Response:

We would like to thank the reviewer for reviewing the manuscript.

Reviewer #2: This is an interesting paper where the authors have studied 64 newly arrived refugees from Syria and Iran living in Michigan USA. They were studied one month after their arrival by making an assessment on PTSD, depression, anxiety, self-reported mental health. neurotrophins- BDNF and NGF as proxy measures of neuroplasticity and exposure to heavy metals. The authors found independent associations between environmental exposures and neuroplasticity with different mental health problems. Few of the findings can be interpreted as different from what one expects.

As the authors argue this is a pioneer study where they have included two important measures, namely exposure to environmental toxins and neurobiological markers for measuring neuroplasticity in addition to classical descriptive studies in refugee trauma. This has certainly given an extra strength to this paper which will ultimately help us to understand refugee trauma mechanism better.

Abstract is well written and well presented. However, I wonder if the authors could avoid using the terminologies like predictor or predicted (e.g. line 49 ) as this is not a longitudinal study and the direction of causality is thus not very obvious. I would suggest the authors to be a little bit careful when they speculate for their findings. In line 64-66, they argue for role of neutrophins as facilitator of apoptosis which is far away from existing knowledge and understanding of its roles.

Introduction. Well written with relevant literatures

Methods: Sample selection is somewhat limited and the sample size is also rather small. Choice of the instruments and statistical methods are quite well explained and good.

Results are presented well both in tables and texts. I am just curious to know if the authors have sometimes thought about using neuroplasticity as a dependent variable in their analyses. It could have been interesting to look that too.

Discussions are also well balanced and presented. However, I think that authors are quite optimistic for using sophisticated biological parameters is studying refugee trauma which is not always possible specially in low-and middle- income countries.

Response:

We would like to thank the reviewer for these valuable suggestions. We agree with the reviewer and have changed the terminology to make it clear that this is a cross-sectional study that cannot prove causality and therefore we have removed terms such as predictive in the Abstract and elsewhere.

As per reviewer’s suggestion, we have now deleted the sentence in line 64-66 of the original Abstract that mentioned role of neutrophins as facilitator of apoptosis.

Since we had hypothesized neuroplasticity to be potential biomarkers for the development of mental health disorders (PTSD, depression and anxiety), we had used it as an independent variable. However, the reviewer raised an interesting point regarding using neuroplasticity as a dependent variable. We ran the requested analysis, revised the text and added a Table 4. Interestingly, in separate linear regressions, the three mental health disorders were each associated with neuroplasticity. However, the models explained substantially lesser variance compared to when they were run as per our proposed model. We thank the reviewer for suggesting this alternative causative model.

We agree with the reviewer that the analysis of these biomarkers may not be possible in low-and middle-income countries due to the financial limitations. We have now acknowledged this as a potential limitation. However, we also believe that if our findings are confirmed in future studies, the costs for these analyses might be justified since measuring these biomarkers allows refugee mental health professionals to focus sparse resources on those with the largest needs.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Kenji Hashimoto, Editor

Dysfunctional neuroplasticity in newly arrived Middle Eastern refugees in the U.S.: Association with environmental exposures and mental health symptoms

PONE-D-19-29424R1

Dear Dr. Arnetz,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Kenji Hashimoto, PhD

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Kenji Hashimoto, Editor

PONE-D-19-29424R1

Dysfunctional neuroplasticity in newly arrived Middle Eastern refugees in the U.S.: Association with environmental exposures and mental health symptoms

Dear Dr. Arnetz:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Kenji Hashimoto

Section Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .